接下来,为大家分享来自JTO Clin Res Rep报道的一例未经治疗的活动性脑转移患者,接受Sotorasib靶向治疗后神经症状完全缓解的病例。
参考文献:
1.https://www.prnewswire.com/news-releases/journal-of-clinical-oncology-publishes-clinical-results-of-adagrasib-as-a-targeted-treatment-for-krasg12c-mutated-nsclc-with-untreated-central-nervous-system-cns-metastases-301853684.html
2.Yeh J, Marks JA, Alzeer AH, Sloan EA, Varghese R, Paudel N, Reuss JE, Bergquist PJ, Liu SV, Kim C. Remarkable Intracranial Response to Sotorasib in a Patient With KRASG12C-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case Report. JTO Clin Res Rep. 2022 Nov 6;3(12):100428. doi: 10.1016/j.jtocrr.2022.100428. PMID: 36471683; PMCID: PMC9719091.
声明:本资料中涉及的信息仅供参考,请遵从医生或其他医疗卫生专业人士的意见或指导。
本文版权归找药宝典所有,任何个人或机构转载需获得找药宝典授权,在授权范围内使用,并标注来源“找药宝典”。
联系客服